NKT cell activation mediates neutrophil IFN-γ production and renal eschemia-reperfusion injury

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5899-5911

  Li, Li ^a   Huang, Liping ^a   Sung, Sun Sang J ^a   Lobo, Peter I ^a   Brown, Michael G ^a,b   Gregg, Randal K ^b   Engelhard, Victor H ^a,b   Okusa, Mark D ^a,b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CD1D ANTIGEN; CD69 ANTIGEN; CELL ADHESION MOLECULE; GAMMA INTERFERON; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; FLOW CYTOMETRY; INNATE IMMUNITY; INTERFERON PRODUCTION; KIDNEY ISCHEMIA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 34247554222     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5899     Document Type: Article

References (50)

1. Star, R. A. 1998. Treatment of acute renal failure. Kidney Int. 54: 1817-1831.
2. Okusa, M. D. 2002. The inflammatory cascade in acute ischemic renal failure. Nephron 90: 133-138.
3. Friedewald, J. J., and H. Rabb. 2004. Inflammatory cells in ischemic acute renal failure. Kidney Int. 66: 486-491.
4. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
5. + T cells and interferon γ. J. Immunol. 176: 3108-3114.
6. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189.
7. Shimamura, K., H. Kawamura, T. Nagura, T. Kato, T. Naito, H. Kameyama, K. Hatakeyama, and T. Abo. 2005. Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell. Immunol. 234: 31-38.
8. Buch, T., F. L. Heppner, C. Tertilt, T. J. Heinen, M. Kremer, F. T. Wunderlich, S. Jung, and A. Waisman. 2005. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2: 419-426.
9. 2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203: 2639-2648.
10. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4: 1164-1165.
11. Manner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
12. Zajonc, D. M., I. Maricic, D. Wu, R. Haider, K. Roy, C. H. Wong, V. Kumar, and I. A. Wilson. 2005. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202: 1517-1526.
13. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21: 573-583.
14. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
15. Miyazawa, S., H. Watanabe, C. Miyaji, O. Hotta, and T. Abo. 2002. Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice. J Lab. Clin. Med. 139: 269-278.
16. + cells mediates early graft loss of syngeneic transplanted islets. J. Exp. Med. 202: 913-918.
17. Brossay, L., D. Jullien, S. Cardell, B. C. Sydora, N. Burdin, R. L. Modlin, and M. Kronenberg. 1997. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159: 1216-1224.
18. Liu, Y., R. D. Goff, D. Zhou, J. Mattner, B. A. Sullivan, A. Khurana, C. Cantu, 3rd, E. V. Ravkov, C. C. Ibegbu, J. D. Altman, et al. 2006. A modified α-galactosyl ceramide for staining and stimulating natural killer T cells. J. Immunol. Methods 312: 34-39.
19. Rabb, H. 2002. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 61: 1935-1946.
20. Li, L., and M. D. Okusa. 2006. Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat. Clin. Pract. Nephrol. 2: 432-444.
21. 2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 111: 2190-2197.
22. + T-lymphocytes mediate ischemia/reperfusion- induced inflammatory responses in mouse liver. J. Clin. Invest. 100: 279-289.
23. + T cells. J. Immunol. 174: 1073-1080.
24. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
25. Fiorina, P., M. J. Ansari, M. Jurewicz, M. Barry, V. Ricchiuti, R. N. Smith, S. Shea, T. K. Means, H. Auchincloss, Jr., A. D. Luster, et al. 2006. Role of CXC chemokine receptor 3 pathway in renal ischemic injury. J. Am. Soc. Nephrol. 17: 716-723.
26. Loetscher, M., B. Gerber, P. Loetscher, S. A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184: 963-969.
27. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182: 1301-1314.
28. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61: 246-257.
29. Neumann, B., K. Emmanuilidis, M. Stadler, and B. Holzmann. 1998. Distinct functions of interferon-γ for chemokine expression in models of acute lung inflammation. Immunology 95: 512-521.
30. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162: 4928-4937.
31. 2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112: 883-891.
32. Feng, L., Y. Xia, T. Yoshimura, and C. B. Wilson. 1995. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 95: 1009-1017.
33. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178: 1041-1048.
34. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170: 827-845.
35. Ethuin, F., B. Gerard, J. E. Benna, A. Boutten, M. A. Gougereot-Pocidalo, L. Jacob, and S. Chollet-Martin. 2004. Human neutrophils produce interferon γ upon stimulation by interleukin-12. Lab. Invest. 84: 1363-1371.
36. Daemen, M. A., C. van't Veer, T. G. Wolfs, and W. A. Buurman. 1999. Ischemia/reperfusion-induced IFN-γ up-regulation: involvement of IL-12 and IL-18. J. Immunol. 162: 5506-5510.
37. Fu, Y. K., S. Arkins, Y. M. Li, R. Dantzer, and K. W. Kelley. 1994. Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of γ interferon and growth hormone. Infect. Immun. 62: 1-8.
38. Fultz, M. J., S. A. Barber, C. W. Dieffenbach, and S. N. Vogel. 1993. Induction of IFN-γ in macrophages by lipopolysaccharide. Int. Immunol. 5: 1383-1392.
39. Puddu, P., M. Carollo, I. Pietraforte, F. Spadaro, M. Tombesi, C. Ramoni, F. Belardelli, and S. Gessani. 2005. IL-2 induces expression and secretion of IFN-γ in murine peritoneal macrophages. J. Leukocyte Biol. 78: 686-695.
40. Puddu, P., L. Fantuzzi, P. Borghi, B. Varano, G. Rainaldi, E. Guillemard, W. Malorni, P. Nicaise, S. F. Wolf, F. Belardelli, and S. Gessani. 1997. IL-12 induces IFN-γ expression and secretion in mouse peritoneal macrophages. J. Immunol. 159: 3490-3497.
41. Rothfuchs, A. G., D. Gigliotti, K. Palmblad, U. Andersson, H. Wigzell, and M. E. Rottenberg. 2001. IFN-αβ-dependent, IFN-γ secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167: 6453-6461.
42. Laouar, Y., F. S. Sutterwala, L. Gorelik, and R. A. Flavell. 2005. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nat. Immunol. 6: 600-607.
43. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166: 5448-5455.
44. Stober, D., R. Schirmbeck, and J. Reimann. 2001. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J. Immunol. 167: 957-965.
45. Yeaman, G. R., J. E. Collins, J. K. Currie, P. M. Guyre, C. R. Wira, and M. W. Fanger. 1998. IFN-γ is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J. Immunol. 160: 5145-5153.
46. Lloyd, A. R., and J. J. Oppenheim. 1992. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13: 169-172.
47. Kirby, A. C., U. Yrlid, and M. J. Wick. 2002. The innate immune response differs in primary and secondary Salmonella infection. J. Immunol. 169: 4450-4459.
48. Frucht, D. M., T. Fukao, C. Bogdan, H. Schindler, J. J. O'Shea, and S. Koyasu. 2001. IFN-γ production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22: 556-560.
49. Ellis, T. N., and B. L. Beaman. 2004. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 112: 2-12.
50. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1-dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23: 96-101.